Xeris Biopharma Holdings, Inc.
Stable formulations for parenteral injection of peptide drugs

Last updated:

Abstract:

Stable formulations for parenteral injection of peptide drugs and methods of using such stable formulations are provided. In particular, the present invention provides stable formulations for parenteral injection of glucagon and methods of using such glucagon formulations to treat hypoglycemia, especially severe hypoglycemia in emergency situations.

Status:
Grant
Type:

Utility

Filling date:

22 Mar 2016

Issue date:

27 Apr 2021